{"groups":[{"description":"Intravenous busulfan (Busulfan®) in combination with fludarabine\n\nBusulfan: Daily intravenous dosing to target AVC\n\nFludarabine: Fludarabine dosing will be based on actual body weight. Fludarabine will be infused over 30 minutes before busulfan treatment dose.\n\nCampath: All patients will receive premedication for Campath (daily doses of 20 mg are repeated for up to five times).\n\nStem Cell Transplant: Infusion of bone marrow and donors(related/ unrelated).","id":"FG000","title":"Busulfan and Fludarabine"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Death"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"50"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"49"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}